This congress offers an executive platform for networking and discussion. Delegates will benefit from the opportunity to:
Hear from and meet with the key innovators in predictive science and translational medicine. Previous attendees include: Executive Director, Safety Assessment, Novartis; Vice President, Translational Patient Safety, AstraZeneca; Head Clinical Pharmacokinetics, Bayer HealthCare.
Discover collaborative solutions to drug development challenges. This summit brings together a host of experts to compare methods for maximising the role of PKPD in early decision-making, implementing exploratory toxicology throughout the pipeline and applying predictive science to multi-target therapies.
Hear from and meet with the key innovators in predictive science and translational medicine. Previous attendees include: Executive Director, Safety Assessment, Novartis; Vice President, Translational Patient Safety, AstraZeneca; Head Clinical Pharmacokinetics, Bayer HealthCare.
Discover collaborative solutions to drug development challenges. This summit brings together a host of experts to compare methods for maximising the role of PKPD in early decision-making, implementing exploratory toxicology throughout the pipeline and applying predictive science to multi-target therapies.
